A magnetic particle chemiluminescence microfluidic chip for quantitative detection of c-reactive protein
A microfluidic chip and reactive protein technology, applied in the field of clinical medicine in vitro diagnosis, can solve the problems of high non-specific background, complex detection process, low sensitivity, etc., to reduce non-specific interference, high degree of integration, accurate and reliable results Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0058] Embodiment 1: horseradish peroxidase-luminol (HRP-luminol) system is used for the detection of C-reactive protein
[0059] 1. Fabrication of microfluidic chip
[0060] 1) Antibody labeling: i) Enzyme-labeled antibody: Weigh 25 mg of HRP and dissolve it in 1.25% glutaraldehyde solution, and let it stand overnight at room temperature; the reacted enzyme solution is eluted with Sephadex G-25 chromatography column and normal saline , the flow rate was controlled at 1ml / min, and the brown effluent was collected; 12.5mg of the anti-C-reactive protein antibody to be diluted to 5ml with normal saline, and added dropwise to the HRP solution while stirring; 0.25ml of 1M pH9.5 carbonate buffer solution, continued Stir for 3 hours; add 0.25ml of 0.2M lysine, mix well, and let stand at room temperature for 2 hours; add an equal volume of saturated ammonium sulfate drop by drop under stirring, and place at 4°C for 1 hour; centrifuge at 3000rpm for half an hour, discard the supernatan...
Embodiment 2
[0069] Embodiment 2: Alkaline phosphatase-adamantane (ALP-AMPPD) system is used for the detection of C-reactive protein
[0070] 1. Fabrication of microfluidic chip
[0071]1) Antibody labeling: i) Enzyme-labeled antibody: 2.5mg ALP (50IU / mg), add 200uL 100mM PB (pH6.8) containing 1.25% glutaraldehyde, mix well, and react overnight at room temperature; Electromagnetic stirring, dialyzed to 50mM PBS (pH7.2), 12 hours, change medium 4 times; 1.5mg C-reactive protein antibody was dissolved in 100uL 1M carbonate solution (pH9.0); activated AP was added to the prepared In protein liquid, mix well, react at 4°C for 24 hours, add 10 μL of 200mM lysine solution, mix well, react at 22°C for 2 hours; dialyze to 50mM PBS (pH7.2) at 4°C, 12 hours, change the medium 4 times; centrifuge, take the supernatant, wash with 50mM TB pH7.4+0.6%BSA+0.05%NaN 3 Dilute 10 times and store at -20°C. ii) Magnetic-labeled antibody: accurately pipette 30 μL of streptavidin-labeled magnetic particles wit...
Embodiment 3
[0079] Example 3: Magnetic Particle Size Screening
[0080] The particle size of magnetic microspheres is small, the specific surface area is large, and the surface contains active groups, so the coupling capacity is large, but the size of magnetic particles is too small to be conducive to magnet collection, so the magnetic particle size screening is carried out.
[0081] Refer to Example 2 for other experimental conditions, and the particle size of the magnetic particles is determined according to the following scheme.
[0082] Magnetic particle sizes of 0.1 μm, 0.5 μm, 1.6 μm, 2 μm, 3 μm, and 10 μm were selected to label the anti-C-reactive protein antibody. The permanent magnet whose magnetic size has been optimized is used in the detection to fix the height of the magnet.
[0083] The experimental results are as follows:
[0084] The particle size of magnetic particles increases sequentially from 0.1μm, 0.5μm, 1.6μm, 2μm, and 3μm. The interference increases at 3μm, and d...
PUM
| Property | Measurement | Unit |
|---|---|---|
| volume | aaaaa | aaaaa |
| width | aaaaa | aaaaa |
| depth | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


